Volume 89 Issue 50 | p. 6 | News of The Week
Issue Date: December 12, 2011

Merck Plans R&D Center in China

Pharmaceuticals: Beijing will be U.S. firm’s R&D headquarters in Asia
Department: Business
Keywords: Beijing, pharmaceutical R&D, outsourcing, translational research

Merck & Co. will spend $1.5 billion on R&D in China over the next five years, with a big chunk of the cash going to build a facility in Beijing that will become the U.S. company’s R&D headquarters for Asia.

By 2014, Merck expects to complete the construction of R&D facilities in Beijing’s Wangjing Park with more than 500,000 sq ft of space. By then, Merck will have 600 people in . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society